- Tytuł:
- INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
- Autorzy:
- Źródło:
- BMC Cancer. 23(1)
Czasopismo naukowe